Date:3/21/2011

nford Wittels & Heisler LLP (SWH) is a boutique class-action litigation law firm with offices in New York, Washington, D.C., and San Francisco. SWH specializes in civil rights and general public interest cases, representing plaintiffs with employment discrimination, labor and wage violations, predatory lending, whistleblower, consumer fraud, and other claims. Along with an expertise in class actions, SWH also represents select individuals and has developed a particular expertise in the representation of executives in employment disputes. For more information, visit www.swhlegal.com.

For more information, contact Jamie Moss, newsPRos, 201-493-1027, jamie@newspros.com

'/>"/>

SOURCE Sanford Wittels & Heisler LLP Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. TV Personality Vanessa Minnillo Teams Up With Bayer and March of Dimes to Launch National Folate Awareness Campaign
2. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
3. Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
4. Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCares Global Consumer Care Division
5. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
6. Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II
7. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
8. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
9. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
10. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
11. Prometheus and Bayer HealthCare Enter into Services Agreement to Conduct Mutational Analysis